Trupanion (TRUP) Projected to Release Quarterly Earnings on Wednesday

Trupanion (NASDAQ:TRUP) is projected to post its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Trupanion to announce earnings of $0.11 per share and revenue of $389.7170 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

Trupanion Stock Up 1.8%

NASDAQ TRUP opened at $24.92 on Tuesday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. The firm has a 50-day simple moving average of $24.39 and a 200 day simple moving average of $26.33. Trupanion has a twelve month low of $21.16 and a twelve month high of $57.00. The stock has a market cap of $1.09 billion, a PE ratio of 42.24 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on TRUP shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Stifel Nicolaus set a $28.00 target price on Trupanion in a research report on Friday, June 26th. Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. Bank of America decreased their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Finally, Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.60.

Insider Transactions at Trupanion

In other news, COO John R. Gallagher sold 3,603 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the completion of the sale, the chief operating officer directly owned 33,065 shares of the company’s stock, valued at $717,179.85. This represents a 9.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president owned 78,062 shares in the company, valued at approximately $1,717,364. This trade represents a 7.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 17,807 shares of company stock worth $394,452 over the last 90 days. 5.58% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Kemnay Advisory Services Inc. acquired a new position in shares of Trupanion during the 4th quarter worth about $64,000. Kelleher Financial Advisors acquired a new stake in Trupanion in the 3rd quarter valued at about $74,000. Advisory Services Network LLC bought a new position in Trupanion during the third quarter worth about $160,000. Tidal Investments LLC bought a new position in Trupanion during the second quarter worth about $212,000. Finally, Renaissance Technologies LLC acquired a new position in Trupanion during the fourth quarter worth approximately $224,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.